|  | 
  
  
 Vaccine Detail
                          
                            | Mycoplasma gallisepticum lpd mutant vaccine |  
                            | Vaccine Information |  
                            | 
							  Vaccine Name: Mycoplasma gallisepticum lpd mutant vaccineTarget Pathogen: Mycoplasma gallisepticumTarget Disease: Chronic respiratory diseaseVaccine Ontology ID: VO_0002857Type: Live, attenuated vaccineStatus: ResearchHost Species as Laboratory Animal Model: Chickenlpd
                            gene engineering:                            
                            
                              Type: Gene mutationDescription: This lpd mutant is from Mycoplasma gallisepticum (Gates et al., 2008).Detailed Gene Information: Click Here.Immunization Route: Intratracheal immunization |  
                            | Host Response |  
                            | Chicken Response 
                              Persistence: An lpd mutant is highly attenuated in chickens (Gates et al., 2008).Efficacy: An lpd mutant induces significant protection in chickens from challenge with wild type Mycoplasma gallisepticum (Gates et al., 2008).Host IgG Fc fragment response 
                                    
                                      Description: Mg 7 vaccinated chickens mounted a strong humoral anti-M. gallisepticum-specific IgG response that was sustained for at least 4 weeks post-exposure.  M. gallisepticum-specific immunoglobulin responses were detected in chickens inoculated with either Mg 7 or R(low) but not in chickens that received 1× PBS alone. The level of M. gallisepticum-specific serum IgG was highest in the R(low) treated animals at both the 2- and 4-week time points, however, the Mg 7 inoculated birds mounted a fairly robust response considering its level of attenuation.  Thus, the Mg 7 vaccine induced significantly higher IgG responses than PBS inoculated chickens, but significantly lower than those inoculated with wild type R(low) (Gates et al., 2008).Detailed Gene Information: Click Here. |  
                  | References |  
                            | Gates et al., 2008: Gates AE, Frasca S, Nyaoke A, Gorton TS, Silbart LK, Geary SJ. Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis. Vaccine. 2008; 26(16); 2010-2019. [PubMed: 18342996]. |  |